Press releasePRNewswire
Kodiak Sciences
KOD · NASDAQ
$92.97+$1.62 (+1.77%)TodayMarket closed ·
Prev close $91.35
Latest news
- NewsShivdeep Dhaliwal
MongoDB, Kodiak Sciences, Navitas Semiconductor, Boeing and Nvidia: Why These 5 Stocks Are on Investors' Radars Today
- NewsAvi Kapoor
Gold Tumbles Over 3%; MongoDB Shares Move Lower
- NewsAvi Kapoor
Dow Dips Over 200 Points; Dallas Fed’s Manufacturing Index Declines In September
- Press releaseGlobe Newswire
4 Explosive Stories Enter the Investor Spotlight
- NewsVandana Singh
Regeneron Eylea Feels the Pinch as Kodiak Advances Extended Dosing for Eye Drug
- NewsVandana Singh
Kodiak Sciences Says Eye Drug on Par with Regeneron's Medicine
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releasePRNewswire
Zenkuda and tabirafusp-ted Meet Primary Endpoints in Pivotal DAYBREAK Trial in wAMD, with Zenkuda Demonstrating a Potential New Standard-of-Care Profile with Strong Immediacy and Sustained Clinical Effect with Majority of Patients on 24-week Dosing Interval Using Strict Treat-to-Dryness Real World Retreatment Criteria.
- Press releasePRNewswire
Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
- Press releasePRNewswire
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results
- Press releasePRNewswire
Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema
- Press releasePRNewswire
Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026
- NewsAvi Kapoor
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
- Press releasePRNewswire
Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference
- Press releasePRNewswire
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results
- Press releasePRNewswire
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
- NewsErica Kollmann
Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers
- Press releasePRNewswire
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- NewsHenry Khederian
Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?
- NewsAvi Kapoor
Oxford Industries Posts Q4 Results, Joins ADMA Biologics, Vor Biopharma And Other Big Stocks Moving Higher On Friday
- NewsShivdeep Dhaliwal
Meta, Kodiak Sciences, Unity Software, Lumentum Holdings And Reddit: Why These 5 Stocks Are On Investors' Radars Today
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Crude Oil Gains 4%; Commercial Metals Posts Mixed Q2 Results
- NewsAvi Kapoor
Dow Falls 250 Points; US Initial Jobless Claims Rise
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releasePRNewswire
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
- Press releasePRNewswire
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
- Press releasePRNewswire
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
- News
10 Health Care Stocks Whale Activity In Today's Session
- NewsAvi Kapoor
Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday
- Press releasePRNewswire
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
- NewsAvi Kapoor
Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday
- Press releasePRNewswire
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releasePRNewswire
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
- NewsAvi Kapoor
Jim Cramer: Kodiak Sciences Is A 'Pure Spec' Stock, Recommends Buying This Utilities Stock
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.